Active, not recruitingPhase 1NCT06713434

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Studying Dystrophic epidermolysis bullosa

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación DEBRA Chile, Niños Piel de Cristal
Intervention
ELK-003 (Standarized Amniotic Fluid Secretome Eye Drops)(biological)
Enrollment
20 enrolled
Eligibility
2 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

Eliksa Therapeutics, Inc. · Centro de la Vision

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06713434 on ClinicalTrials.gov

Other trials for Dystrophic epidermolysis bullosa

Additional recruiting or active studies for the same condition.

See all trials for Dystrophic epidermolysis bullosa →

← Back to all trials